Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
Contineum Therapeutics Inc (NASDAQ: CTNM) closed the day trading at $11.39 down -0.78% from the previous closing price of $11.48. In other words, the price has decreased by -$0.78 from its previous closing price. On the day, 0.55 million shares were traded. CTNM stock price reached its highest trading level at $11.75 during the session, while it also had its lowest trading level at $11.38.
Ratios:
For a better understanding of CTNM, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 29.07 and its Current Ratio is at 29.07. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In the most recent recommendation for this company, Leerink Partners on November 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $22.
On September 25, 2025, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CTNM now has a Market Capitalization of 416070432 and an Enterprise Value of 155474800.
Stock Price History:
The Beta on a monthly basis for CTNM is 1.12, which has changed by -0.14962965 over the last 52 weeks, in comparison to a change of 0.13329959 over the same period for the S&P500. Over the past 52 weeks, CTNM has reached a high of $15.25, while it has fallen to a 52-week low of $3.35. The 50-Day Moving Average of the stock is 0.59%, while the 200-Day Moving Average is calculated to be 47.00%.
Shares Statistics:
Over the past 3-months, CTNM traded about 180.68K shares per day on average, while over the past 10 days, CTNM traded about 305810 shares per day. A total of 36.53M shares are outstanding, with a floating share count of 25.07M. Insiders hold about 31.37% of the company’s shares, while institutions hold 38.41% stake in the company. Shares short for CTNM as of 1764288000 were 1048944 with a Short Ratio of 5.81, compared to 1761868800 on 1224141. Therefore, it implies a Short% of Shares Outstanding of 1048944 and a Short% of Float of 5.0100001999999995.
Earnings Estimates
A detailed examination of Contineum Therapeutics Inc (CTNM) is currently in progress, with 7.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.49 and low estimates of -$0.76.
Analysts are recommending an EPS of between -$1.19 and -$2.28 for the fiscal current year, implying an average EPS of -$2.05. EPS for the following year is -$2.24, with 7.0 analysts recommending between -$1.9 and -$2.74.
